Navigation Links
Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings
Date:12/3/2008

rmalities were observed during the study. The only side effect observed was mild loose stools (12% in treatment group vs. 3% in the placebo group). To date, no significant toxicities have been observed in any of the animal studies with doses ranging from 2000 mg/kg/day in dogs to 16,000 mg/kg/day in rodents.

"The positive results of Menerba to date are very encouraging. Our discussions with the FDA clinical staff, our Scientific Advisory Board, our clinical investigators, and our reception at the many scientific conferences at which we have presented -- all have served to strengthen our confidence that Bionovo's Menerba will be able to provide menopausal women with a safe and efficacious alternative to the existing drugs on the market. This is particularly important because all current drugs for hot flashes carry six black box warnings by the FDA for potentially serious adverse events. As a next step, we have plans to meet with the clinical review team at the FDA to reach an agreement on the clinical path forward," said Dr. Mary Tagliaferri, M.D., Bionovo's President and Chief Medical Officer.

"Menerba provides a true paradigm shift in the treatment of menopausal hot flashes. The novel mechanism of action, the exciting preclinical and clinical safety, and the early efficacy are encouraging. I believe swift development is warranted so we can provide women with an alternative to hormone therapy," said Wulf Utian, M.D., Ph.D., D.Sc. Founder and President Emeritus of the

North American Menopause Society and Menerba's Principal Clinical Investigator.

The Company expects to initiate clinical trials by the second quarter of 2009 subject to FDA review.

About Menerba

Menerba is an estrogen receptor (ER) beta selective drug developed as an alternative to postmenopausal hormone products currently on the market, which are both ER beta and ER alpha agonists that have been shown
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Bionovo Announces Positive Developments in On-going Phase 1/2 Cancer Drug Trial
2. Bionovo Announces Publication of the Paper Detailing the Mechanism of Action of Its Cancer Drug BZL101
3. Bionovo Discovers New Estrogen Regulatory Elements for Breast Cancer and Osteoporosis Drugs
4. Bionovos Drug Candidate for Menopausal Symptoms Shows Effect on Neural Pathways Related to Temperature Regulation
5. Bionovo Elucidates Mechanism of Breast Cancer Control by Estrogen Receptor Beta
6. Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate
7. Bionovos MF101 Shows Statistically Significant Improvement in Sleep Disturbance from Hot Flashes
8. Bionovos VG101 Shows Greater Efficacy Than Estrogen in the Treatment of Vaginal Dryness
9. Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer
10. Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology
11. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... 2014 A study led by St. ... chemotherapy dose threshold below which male childhood cancer survivors ... appears in September 17 edition of the journal ... are at highest risk for reduced sperm production as ... of pre-treatment fertility preservation methods such as sperm banking. ...
(Date:9/16/2014)... CHICAGO , Sept. 16, 2014 The ... submitted survey data from more than 1,100 patients and ... Food and Drug Administration (FDA) for the Patient-Focused Drug ... This is a new FDA initiative to seek patient ... expectations for therapeutic treatments. "We applaud the ...
(Date:9/16/2014)... 2014 Astellas announced today it has ... & Advocacy, Urology in the Americas. Noland will report ... Margaret Long. In this role, Noland will be responsible ... and advocacy organizations, as well as collaborating with ... Noland,s appointment is the latest phase in the ...
Breaking Medicine Technology:Improved risk identification will aid fertility preservation in young male cancer patients 2Improved risk identification will aid fertility preservation in young male cancer patients 3Improved risk identification will aid fertility preservation in young male cancer patients 4PFF Submits Survey Data From More Than 1,100 Pulmonary Fibrosis Patients And Families To U.S. Food And Drug Administration For Upcoming Drug Development Meeting 2PFF Submits Survey Data From More Than 1,100 Pulmonary Fibrosis Patients And Families To U.S. Food And Drug Administration For Upcoming Drug Development Meeting 3PFF Submits Survey Data From More Than 1,100 Pulmonary Fibrosis Patients And Families To U.S. Food And Drug Administration For Upcoming Drug Development Meeting 4Christy Noland to Lead Urology Advocacy and Communications for Astellas 2
(Date:9/17/2014)... CA (PRWEB) September 17, 2014 Altec ... workflow solutions, announced today their Gold Sponsorship of the ... CONNECT 2014. The annual conference will take place in ... 21 – 23 and is organized and hosted by ... a non-profit organization comprised of members from more than ...
(Date:9/17/2014)... 17, 2014 Tina Griffin, a Senior Sales ... her chemotherapy but not her fight against cancer. Though weakened ... Florida Suncoast “Race for the Cure” on Saturday, Oct. 11, ... Komen Race for the Cure because I wanted to make ... , As part of her efforts, she is asking those ...
(Date:9/17/2014)... September 17, 2014 Kristen Yarker, MSc, RD ... parents of children 9 months to 2 years old who ... furthermore, prevent picky eaters from developing by encouraging healthy eating ... (9 months to 2 years): How to Transition From Baby ... Is Getting the Nutrition They Need)” is a new online ...
(Date:9/17/2014)... Angeldress.co.uk is a popular online supplier; it offers ... clients. According to Leo, the company’s marketing specialist, its ... retail store. Moreover, it is a market leader in ... new range of amazing wedding dresses and launched a ... offered at greatly discounted prices, from 20% off to ...
(Date:9/17/2014)... September 17, 2014 There’s something ... giving girls of all ages an all-natural option ... founded by women, for women, announces the launch ... (http://GirlU.com) to relieve the symptoms commonly associated ... irritability. , As a lifelong health enthusiast ...
Breaking Medicine News(10 mins):Health News:Altec Joins the 2014 Epicor Prophet 21 World Wide User Group Conference as a Gold Sponsor 2Health News:Altec Joins the 2014 Epicor Prophet 21 World Wide User Group Conference as a Gold Sponsor 3Health News:Tina Griffin’s Fight Against Cancer Didn’t Stop With her Chemotherapy—Her Next Step Is to Run in the Suncoast ‘Race for the Cure’ Oct. 11 2Health News:Nutritionist Kristen Yarker Offers Parents a Fresh Approach to Prevent Picky Eaters in New Online Seminar 2Health News:Nutritionist Kristen Yarker Offers Parents a Fresh Approach to Prevent Picky Eaters in New Online Seminar 3Health News:Angeldress.co.uk Is Planning To Open Its First Retail Store And Offering Big Savings On Amazing Wedding Dresses 2Health News:Girl Uninterrupted® Debuts New Look for All-Natural, PMS-Relief Supplement, Launching Today 2Health News:Girl Uninterrupted® Debuts New Look for All-Natural, PMS-Relief Supplement, Launching Today 3Health News:Girl Uninterrupted® Debuts New Look for All-Natural, PMS-Relief Supplement, Launching Today 4
... Heart patients and cardiologists across the country are ... access be preserved as discussions about healthcare ... for Medicare and Medicaid Services (CMS) - scheduled to ... the accessibility of life-saving cardiology testing and services currently ...
... Health System study has found that high-risk surgery ... were seen by general internists trained in managing ... underwent high-risk orthopaedic surgeries experienced shorter stays when ... surgeons. And, the study found, patients reported they ...
... true for current H1N1 strain remains a mystery, , THURSDAY, ... 1918 Spanish flu pandemic while still in their mother,s womb ... 60 years later, a new study has found. , The ... people worldwide, including 500,000 in the United States. That flu, ...
... Effort Illustrates Broad Public Support for Addressing Crisis ... Oct. 1 Citizens of Delaware ... and wellness with the launch today of "Say ,Yes, to ... video campaign of the Partnership to Fight Chronic Disease (PFCD) ...
... Pink Sheets Filings Reply To Shareholders ... General Corporate Update, , SHENZHEN, China, Oct. 1 /PRNewswire-FirstCall/ ... based operating subsidiary Mellow Hope and Serbia operating Subsidiary ... attention to today,s Pink Sheets filing. The filing found ...
... Whether they can have children is one of the ... cancer because fertility can be compromised by cancer treatment. ... studies led by researchers at Fred Hutchinson Cancer Research ... will adversely impact their newborns. The studies, presented as ...
Cached Medicine News:Health News:Proposed Medicare Changes Will Increase Costs to Government, Decrease Options for Patients 2Health News:Proposed Medicare Changes Will Increase Costs to Government, Decrease Options for Patients 3Health News:How to reduce hospital stays and increase patient satisfaction 2Health News:Pre-Birth Exposure to 1918 Flu Raised Heart Risks, Study Finds 2Health News:Pre-Birth Exposure to 1918 Flu Raised Heart Risks, Study Finds 3Health News:Delaware Residents Participate in Launch of National Video Campaign: 'Say 'Yes' to Health Reform' 2Health News:Delaware Residents Participate in Launch of National Video Campaign: 'Say 'Yes' to Health Reform' 3Health News:Hard to Treat Diseases (HTDS) Management Discussion 2Health News:Hard to Treat Diseases (HTDS) Management Discussion 3Health News:Studies find few risks to newborn offspring of parents who are childhood cancer survivors 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: